C37H62O12
Neat
698.89
Laidlomycin; 56283-74-0; Laidlomycine; Laidlomicina; Laidlomycinum; MI3S6ZF5QE; DTXSID401024015; Monensin, 16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-; (2S, 3R, 4R)-4-[(2S, 5R, 7S, 8R, 9S)-7-hydroxy-2-[(2R, 5S)-5-[(2R, 3S, 5R)-5-[(2S, 3S, 5R, 6R)-6-hydroxy-6-(hydroxymethyl)-3, 5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2, 8-dimethyl-1, 10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid; (2S, 3R, 4R)-4-((2S, 5R, 7S, 8R, 9S)-7-hydroxy-2-((2R, 5S)-5-((2R, 3S, 5R)-5-((2S, 3S, 5R, 6R)-6-hydroxy-6-(hydroxymethyl)-3, 5-dimethyloxan-2-yl)-3-methyloxolan-2-yl)-5-methyloxolan-2-yl)-2, 8-dimethyl-1, 10-dioxaspiro(4.5)decan-9-yl)-2-methyl-3-propanoyloxypentanoic acid; RefChem:57502; CSU-1; DTXCID201508302; 4-(7-hydroxy-2-(5-(5-(6-hydroxy-6-(hydroxymethyl)-3, 5-dimethyloxan-2-yl)-3-methyloxolan-2-yl)-5-methyloxolan-2-yl)-2, 8-dimethyl-1 and 10-dioxaspiro(4.5)decan-9-yl)-2-methyl-3-propanoyloxypentanoic acid; 16-Deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl) monensin; 260-095-1; Laidlomycin [INN:BAN]; UNII-MI3S6ZF5QE; Laidlomycine [INN-French]; Laidlomycinum [INN-Latin]
(2S, 3R, 4R)-4-[(2S, 5R, 7S, 8R, 9S)-7-hydroxy-2-[(2R, 5S)-5-[(2R, 3S, 5R)-5-[(2S, 3S, 5R, 6R)-6-hydroxy-6-(hydroxymethyl)-3, 5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2, 8-dimethyl-1 and 10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid
InChI=1S/C37H62O12/c1-10-28(40)45-30(24(7)33(41)42)23(6)31-22(5)25(39)17-36(47-31)14-13-34(8,49-36)27-11-12-35(9,46-27)32-20(3)16-26(44-32)29-19(2)15-21(4)37(43,18-38)48-29/h19-27,29-32,38-39,43H,10-18H2,1-9H3,(H,41,42)/t19-,20-,21+,22+,23-,24-,25-,26+,27+,29-,30+,31-,32+,34-,35-,36+,37-/m0/s1